1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Travel Vaccine Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Travel Vaccine Market
4. United States Travel Vaccine
Market by Composition
4.1. Mono Vaccine
4.2. Combination Vaccines
5. United States Travel Vaccine
Market by Type
5.1. Attenuated Vaccines
5.2. Inactive Vaccines
5.3. Subunit Vaccines
5.4. Toxoid Vaccines
5.5. Conjugate Vaccines
5.6. DNA Vaccines
5.7. Recombinant Vector Vaccines
6. Company Profiles
6.1. Company 1
6.2. Company 2
6.3. Company 3
6.4. Company 4
6.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Travel Vaccine Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Travel Vaccine Market
4. United States Travel Vaccine
Market by Composition
4.1. Mono Vaccine
4.2. Combination Vaccines
5. United States Travel Vaccine
Market by Type
5.1. Attenuated Vaccines
5.2. Inactive Vaccines
5.3. Subunit Vaccines
5.4. Toxoid Vaccines
5.5. Conjugate Vaccines
5.6. DNA Vaccines
5.7. Recombinant Vector Vaccines
6. Company Profiles
6.1. Company 1
6.2. Company 2
6.3. Company 3
6.4. Company 4
6.5. Company 5